Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner

Documenti analoghi

• Identification of luteolin-7-glucoside metabolites after oral administration and development of a method for their quantitative analysis
  di: G. V. Adamov, et al.
  Pubblicazione: (2024-09-01)
• Formation of quercetin from taxifolin and quercetin 7-O-glucoside from taxifolin 7-O-glucoside by cooking sorghum grains: Possible mechanisms of their formation
  di: Umeo Takahama, et al.
  Pubblicazione: (2024-06-01)
• Exploring the potential of Ziziphus nummularia and luteolin-7-O-glucoside as tubulin inhibitors in cancer therapy and survival
  di: Sahar Saleh Alghamdi, et al.
  Pubblicazione: (2024-03-01)
• Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  di: Li Yan, et al.
  Pubblicazione: (2024-03-01)
• The Anti-Biofilm Activity and Mechanism of Apigenin-7-O-Glucoside Against Staphylococcus aureus and Escherichia coli
  di: Pei ZJ, et al.
  Pubblicazione: (2023-04-01)